Programmed Death-1 or Programmed Death Ligand-1 Blockade in Patients with Platinum-resistant Metastatic Urothelial Cancer: A Systematic Review and Meta-analysisScot A. Niglio, Matthew D. Galsky, Rachel Jia et al.|European Urology|2019Cited by 109
Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle‐invasive bladder cancerAlberto Martini, Matthew D. Galsky, Rachel Jia et al.|Cancer|2019Cited by 47
Telemedicine-Enabled Clinical Trial of Metformin in Patients With Prostate CancerMatthew D. Galsky, William Oh, Charles Baker et al.|JCO Clinical Cancer Informatics|2017Cited by 26